Literature DB >> 3368065

Clinical and angiographic comparison of asymptomatic occlusive cerebrovascular disease.

P B Gorelick1, L R Caplan, P Langenberg, D B Hier, M Pessin, D Patel, J Taber.   

Abstract

We compared clinical and arteriographic features in 106 patients with symptomatic unilateral carotid territory occlusive disease to determine the frequency and distribution of occlusive arterial lesions in asymptomatic vessels. Among black patients who were predominantly from Chicago, young, and female, there were fewer transient ischemic attacks and myocardial infarcts, less claudication, and more asymptomatic lesions of the supraclinoid internal carotid artery, anterior cerebral artery stem, and the middle cerebral artery stem. Among white patients predominantly from New England, elderly, and male, there was more frequent and severe occlusive asymptomatic disease at extracranial carotid and vertebral artery sites. Knowledge of the distribution of asymptomatic lesions will help guide evaluation and treatment strategies for patients with occlusive cerebrovascular disease.

Entities:  

Mesh:

Year:  1988        PMID: 3368065     DOI: 10.1212/wnl.38.6.852

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic korean population.

Authors:  Kwang-Yeol Park; Chin-Sang Chung; Kwang Ho Lee; Gyoeng-Moon Kim; Yong-Bum Kim; Kyungmi Oh
Journal:  J Clin Neurol       Date:  2006-03-20       Impact factor: 3.077

Review 2.  Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment.

Authors:  Christine A Holmstedt; Tanya N Turan; Marc I Chimowitz
Journal:  Lancet Neurol       Date:  2013-11       Impact factor: 44.182

3.  The hepatitis B core antibody positive/hepatitis B surface antigen negative pattern is associated with the increased risk of intracranial atherosclerotic stenosis.

Authors:  Lin Shen; Huchuan Zhou; Fei Wei; Jie Shuai
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.